GGrantIndex
← Leaderboards

Thomas D. Hurley

Indiana University Indianapolis

$11,294,425
Attributed
$14,747,220
Total exposure
18
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,747,220 · 18

By mechanism

R01$8,568,515 · 5
TL1$2,545,600 · 1
R21$1,374,826 · 4
T32$1,017,408 · 2
S10$498,292 · 2
P01$436,628 · 1

Most similar at Indiana University Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Lead

Research focus

LeadBaseInhibitor/AntagonistActive SitesSmall MoleculeUniversitiesAldehyde DehydrogenasesStructureEnzymesStructure-Activity RelationshipAnalogPropertyHigh Throughput ScreeningInstitutesBinding (Molecular Function)GenerationsFutureCellsAcetaldehydeIndianaDrug KineticsLaboratoriesDesignMitochondria

Grant awards (49)

CTSA Postdoctoral T32 at Indiana University$251,586
T32 · FY2025 · TR · contact PI
IMSD at Indiana University School of Medicine through Inclusive Biomedical Research Training Program$344,844
T32 · FY2024 · GM · contact PI
CTSA Postdoctoral T32 at Indiana University$253,555
T32 · FY2024 · TR · contact PI
IMSD at Indiana University School of Medicine through Inclusive Biomedical Research Training Program$167,423
T32 · FY2023 · GM · contact PI
NRSA Training Core$560,786
TL1 · FY2022 · TR · contact PI
NRSA Training Core$520,523
TL1 · FY2021 · TR · contact PI
NRSA Training Core$514,328
TL1 · FY2020 · TR · contact PI
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$513,407
R01 · FY2020 · DK · contact PI
Suppressing glycogen storage with small molecule inhibitors as a therapeutic approach to Lafora Disease$436,628
P01 · FY2020 · NS · contact PI
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$513,407
R01 · FY2019 · DK
NRSA Training Core$482,131
TL1 · FY2019 · TR · contact PI
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$513,407
R01 · FY2018 · DK
NRSA Training Core$467,832
TL1 · FY2018 · TR · contact PI
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$303,649
R01 · FY2017 · DK
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$324,516
R01 · FY2016 · DK
Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1$169,467
R21 · FY2016 · CA · contact PI
Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1$203,397
R21 · FY2015 · CA · contact PI
SMALL MOLECULE INHIBITION OF GLYCOGEN STORAGE AS THERAPY FOR GLYCOGENOSES$185,498
R56 · FY2015 · DK
Structural Determinants of Glycogen Synthase Regulation$329,168
R01 · FY2014 · DK · contact PI
Activation and Inhibition of Aldehyde Dehydrogenase 2$323,680
R01 · FY2013 · AA · contact PI
Structural Determinants of Glycogen Synthase Regulation$317,787
R01 · FY2013 · DK · contact PI
Activation and Inhibition of Aldehyde Dehydrogenase 2$348,043
R01 · FY2012 · AA · contact PI
Structural Determinants of Glycogen Synthase Regulation$329,455
R01 · FY2012 · DK · contact PI
X8 Prospector for Macromolecular Crystallography$453,292
S10 · FY2011 · RR · contact PI
Activation and Inhibition of Aldehyde Dehydrogenase 2$440,616
R01 · FY2011 · AA · contact PI
Structural Determinants of Glycogen Synthase Regulation$379,715
R01 · FY2011 · DK · contact PI
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence$185,031
R21 · FY2011 · AA
Activation and Inhibition of Aldehyde Dehydrogenase 2$455,863
R01 · FY2010 · AA · contact PI
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence$231,000
R21 · FY2010 · AA
Activation and Inhibition of Aldehyde Dehydrogenase 2$365,750
R01 · FY2009 · AA · contact PI
Quantification of human alcohol metabolizing enzymes by mass spectrometry$179,313
R21 · FY2009 · AA
Activation and Inhibition of Aldehyde Dehydrogenase 2$64,566
R01 · FY2009 · AA · contact PI
X-ray Structure of Human Aldehyde Dehydrogenase$288,971
R01 · FY2008 · AA · contact PI
Quantification of human alcohol metabolizing enzymes by mass spectrometry$217,243
R21 · FY2008 · AA
Inhibition of s-nitrosoglutathione reductase for the treatment of asthma$189,375
R21 · FY2008 · HL · contact PI
X-ray Structure of Human Aldehyde Dehydrogenase$288,971
R01 · FY2007 · AA · contact PI
X-ray Structure of Human Aldehyde Dehydrogenase$297,600
R01 · FY2006 · AA · contact PI
Structural Determinants of Glycogen Initiation$225,064
R01 · FY2006 · DK · contact PI
X-ray Structure of Human Aldehyde Dehydrogenase$304,763
R01 · FY2005 · AA
Structural Determinants of Glycogen Initiation$230,682
R01 · FY2005 · DK
X-ray Structure of Human Aldehyde Dehydrogenase$304,763
R01 · FY2004 · AA
Structural Determinants of Glycogen Initiation$230,875
R01 · FY2004 · DK
TIME-RESOLVED DATA: MITOCHONDRIAL ALDEHYDE DEHYDROGENASE$6,631
P41 · FY2004 · RR
Structural Determinants of Glycogen Initiation$343,932
R01 · FY2003 · DK
X RAY STRUCTURE OF HUMAN ALDEHYDE DEHYDROGENASE$180,496
R01 · FY2002 · AA
X RAY STRUCTURE OF HUMAN ALDEHYDE DEHYDROGENASE$175,236
R01 · FY2001 · AA
X RAY STRUCTURE OF HUMAN ALDEHYDE DEHYDROGENASE$174,133
R01 · FY2000 · AA
STRUCTURE-BASED LIGAND DESIGN FOR ALCOHOL DEHYDROGENASE$113,822
R29 · FY2000 · AA
PROCISE 491 CLC PROTEIN SEQUENCER$45,000
S10 · FY2000 · RR